Colestipol: Difference between revisions

(Prepared the page for translation)
(Marked this version for translation)
 
Line 2: Line 2:
<translate>
<translate>


==Administration==
==Administration== <!--T:1-->


<!--T:2-->
*Type: Bile Acid Binder
*Type: Bile Acid Binder
*Dosage Forms: 1 g tab; 5 g/scoop granules; 5 g granule packet
*Dosage Forms: 1 g tab; 5 g/scoop granules; 5 g granule packet
Line 10: Line 11:




==Adult Dosing==
==Adult Dosing== <!--T:3-->


<!--T:4-->
*[[Special:MyLanguage/Digoxin toxicity|Digoxin toxicity]], adjunct tx
*[[Special:MyLanguage/Digoxin toxicity|Digoxin toxicity]], adjunct tx
**Granules: 5 g PO q6-8h
**Granules: 5 g PO q6-8h
Line 42: Line 44:




==Pediatric Dosing==
==Pediatric Dosing== <!--T:5-->


<!--T:6-->
Pediatric dosing currently unavailable.
Pediatric dosing currently unavailable.




==Special Populations==
==Special Populations== <!--T:7-->


<!--T:8-->
*[[Special:MyLanguage/Drug pregnancy categories|Pregnancy Rating]]: C; Inadequate data to assess risk
*[[Special:MyLanguage/Drug pregnancy categories|Pregnancy Rating]]: C; Inadequate data to assess risk
*Lactation risk: L3; Safety unknown
*Lactation risk: L3; Safety unknown




===Renal Dosing===
===Renal Dosing=== <!--T:9-->


<!--T:10-->
*Adult: No adjustment
*Adult: No adjustment
*Pediatric: N/A
*Pediatric: N/A


===Hepatic Dosing===
===Hepatic Dosing=== <!--T:11-->


<!--T:12-->
*Adult: Not defined.
*Adult: Not defined.
*Pediatric: N/A
*Pediatric: N/A




==Contraindications==
==Contraindications== <!--T:13-->


<!--T:14-->
*Allergy to class/drug
*Allergy to class/drug
*Caution if constipation
*Caution if constipation
Line 71: Line 78:




==Adverse Reactions==
==Adverse Reactions== <!--T:15-->




===Serious===
===Serious=== <!--T:16-->


<!--T:17-->
*Fecal impaction
*Fecal impaction
*[[Special:MyLanguage/PUD|PUD]]
*[[Special:MyLanguage/PUD|PUD]]
Line 83: Line 91:




===Common===
===Common=== <!--T:18-->


<!--T:19-->
*[[Special:MyLanguage/Constipation|Constipation]]
*[[Special:MyLanguage/Constipation|Constipation]]
*Abdominal pain
*Abdominal pain
Line 98: Line 107:




==Pharmacology==
==Pharmacology== <!--T:20-->


<!--T:21-->
*Half-life: Unknown
*Half-life: Unknown
*Metabolism: N/A
*Metabolism: N/A
Line 105: Line 115:




==Mechanism of Action==
==Mechanism of Action== <!--T:22-->


<!--T:23-->
Binds intestinal bile acids for excretion.
Binds intestinal bile acids for excretion.




==Comments==
==Comments== <!--T:24-->




==See Also==
==See Also== <!--T:25-->


<!--T:26-->
[[Special:MyLanguage/Digoxin toxicity|Digoxin toxicity]]
[[Special:MyLanguage/Digoxin toxicity|Digoxin toxicity]]




==References==
==References== <!--T:27-->


<!--T:28-->
<references/>
<references/>


<!--T:29-->
[[Category:Pharmacology]]
[[Category:Pharmacology]]
[[Category:GI]]
[[Category:GI]]
[[Category:Toxicology]]
[[Category:Toxicology]]
</translate>
</translate>

Latest revision as of 12:34, 7 January 2026

Other languages:

Administration

  • Type: Bile Acid Binder
  • Dosage Forms: 1 g tab; 5 g/scoop granules; 5 g granule packet
  • Routes of Administration: Oral
  • Common Trade Names: N/A


Adult Dosing

  • Digoxin toxicity, adjunct tx
    • Granules: 5 g PO q6-8h
      • Start: 10 g PO x1 within 1-3h after last oral digoxin ingestion
      • Max: 30 g/day
  • Gallbladder surgery-associated diarrhea, adjunct tx
    • Tabs: 2-16 g/day PO divided QD-QID
      • Start: 2 g PO QD-bid
      • Max: 16 g/day.
      • Do not crush/cut/chew
    • Granules:5-30 g/day PO divided QD-QID
      • Start: 5 g PO QD-bid
      • Max: 30 g/day
  • Hypercholesterolemia
    • Tabs: 2-16 g/day PO divided QD-QID
      • Start: 2 g PO QD-bid
      • Max: 16 g/day.
      • Do not crush/cut/chew
    • Granules:5-30 g/day PO divided QD-QID
      • Start: 5 g PO QD-bid
      • Max: 30 g/day
  • Pruritus secondary to biliary obstruction
    • Tabs: 2-16 g/day PO divided QD-QID
      • Start: 2 g PO QD-bid
      • Max: 16 g/day.
      • Do not crush/cut/chew
    • Granules:5-30 g/day PO divided QD-QID
      • Start: 5 g PO QD-bid
      • Max: 30 g/day


Pediatric Dosing

Pediatric dosing currently unavailable.


Special Populations

  • Pregnancy Rating: C; Inadequate data to assess risk
  • Lactation risk: L3; Safety unknown


Renal Dosing

  • Adult: No adjustment
  • Pediatric: N/A

Hepatic Dosing

  • Adult: Not defined.
  • Pediatric: N/A


Contraindications

  • Allergy to class/drug
  • Caution if constipation
  • Caution if prolonged use


Adverse Reactions

Serious


Common


Pharmacology

  • Half-life: Unknown
  • Metabolism: N/A
  • Excretion: Feces


Mechanism of Action

Binds intestinal bile acids for excretion.


Comments

See Also

Digoxin toxicity


References